Prescribing Practices of Recommended Treatment for Trichomonas vaginalis and Chlamydia trachomatis after 2021 STI Treatment Guideline Update

Christen J Arena; Rachel M Kenney; Erin Eriksson; Indira Brar; Michael P Veve

doi:10.1097/OLQ.0000000000001987

Prescribing Practices of Recommended Treatment for Trichomonas vaginalis and Chlamydia trachomatis after 2021 STI Treatment Guideline Update

Sex Transm Dis. 2024 May 6. doi: 10.1097/OLQ.0000000000001987. Online ahead of print.

Authors

Christen J Arena¹, Rachel M Kenney¹, Erin Eriksson², Indira Brar³, Michael P Veve

Affiliations

¹ Department of Pharmacy, Henry Ford Hospital, Detroit, MI.
² Department of Pharmacy, Henry Ford Allegiance Health, Jackson, MI.
³ Department of Infectious Diseases, Henry Ford Hospital, Detroit, MI.

PMID: 38709026
DOI: 10.1097/OLQ.0000000000001987

Abstract

We evaluated the proportion of patients with trichomoniasis and chlamydial infections who received recommended versus non-recommended antibiotic therapy after the updated 2021 Sexually Transmitted Infections Guideline. Of 712 patients, 473 (66%) received recommended therapy. Receipt of emergency department care was independently associated with recommended therapy (adjOR, 2.1; 95% CI 1.5-2.9).